Are you a strategic thinker with a passion for software solutions for safer use of medicines? We are looking for a Product Manager to drive development of our standardisation portfolio to meet user needs and regulatory requirements. With us, you will work in a multicultural and dynamic environment where you will engage with stakeholders to secure buy-in for our products. This is a temporary, full-time position from 15 February to 31 December.
Since 1978, Uppsala Monitoring Centre (UMC) has been dedicated to developing, supporting, and expanding the field of pharmacovigilance science and practice.
As a World Health Organization (WHO) Collaborating Centre, we support work around the world to examine the potential adverse effects of medicines and vaccines and contribute to safer, more informed care of patients.
We are a diverse, international group of pharmacists, physicians, data scientists, system developers, communicators, and many other professionals motivated by a deep belief that the work we do matters.
As a Product Manager, you will be focusing on UMC’s standardisation portfolio. In close collaboration with colleagues, you will nurture customer relationships to ensure fit-for-purpose products and services. You will actively seek an understanding of current and future needs and act as a bridge between the market and UMC’s product owners. You will weigh risk, benefit, and cost to optimise value for all stakeholders. In terms of software development, you will add knowledge to the product team and leverage the use of AI. You will also represent UMC externally and act as an ambassador for the portfolio. You will report to the Head of Product Management.
Qualifications and experience:
We would also welcome:
As a person, we would like you to have:
#LI-DNI

Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978 dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance, and maintains VigiBase, the WHO global database of adverse event reports.
In addition, UMC provides international standards and related digital solutions for secure exchange of pharmacovigilance data, including a global medicine and vaccine terminology for identification of medicinal products. With around 200 staff, UMC advances the science of pharmacovigilance and transforms its practice through technological innovation.